Shilpa Medicare declines on getting 15 observations from USFDA for Telangana Facility

26 Feb 2020 Evaluate

Shilpa Medicare is currently trading at Rs. 489.45, down by 25.75 points or 5.00% from its previous closing of Rs. 515.20 on the BSE.

The scrip opened at Rs. 522.70 and has touched a high and low of Rs. 538.75 and Rs. 489.45 respectively. So far 29606 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 538.75 on 26-Feb-2020 and a 52 week low of Rs. 190.80 on 04-Sep-2019.

Last one week high and low of the scrip stood at Rs. 538.75 and Rs. 451.00 respectively. The current market cap of the company is Rs. 3990.33 crore.

The promoters holding in the company stood at 53.80%, while Institutions and Non-Institutions held 26.89% and 19.31% respectively.

US Food and Drug Administration (USFDA) has conducted Good Manufacturing Practices (GMP) inspection of Shilpa Medicare’s Finished Dosage Formulation Facility (Sterile and Non-sterile) located at S-20 to S-26, Pharmaceutical Formulations SEZ, TSIIC, Jadcherla, Telangana State, India from February 13-25, 2020.

At the conclusion of inspection, the Agency issued Form 483, with 15 observations. The company is preparing responses to the observations, which will be submitted to the Agency within 15 business days. The company is committed to address these observations promptly.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.


Shilpa Medicare Share Price

484.85 15.90 (3.39%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.